Global Cough, Cold & Allergy (CCA) Treatment Market (By Product Category, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Global Cough, Cold & Allergy (CCA) Treatment Market (By Product Category, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

The global cough, cold & allergy (CCA) treatment market is expected to reach US$35.36 billion in 2024, growing at a CAGR of 3.90%, for the duration spanning 2020-2024. The factors such as rising demand for over-the-counter (OTC) medicines, upswing in air pollution, growth in the geriatric population, increasing pharmaceutical R&D spending, rising prevalence of asthma and upsurge in healthcare expenditures would drive the growth of the market. However, the market growth would be challenged by abusive use of OTC CCA drugs, threats associated with drugs counterfeiting and legal regulations. A few notable trends may include escalating demand for antihistamines nasal therapy, accelerating growth rates of infectious diseases, increasing focus on telehealth and growth in pharmaceutical & biotech merger & acquisition.

The global CCA treatment market is highly competitive and consolidated in nature. The market is comprised of large multinational players as well as a few smaller and local players. Such players continue to invest considerable funds in developing new drugs in the market, which is resulting in the expansion of the CCA drug portfolio and thereby significantly contributing to its market growth on a global scale.

The fastest growing regional market is the U.S., due to the presence of the well established pharmaceutical brands, having a strong brand image and brand loyal consumers, which has supported the consolidation of the market. Further, the sudden outbreak of the COVID-19 pandemic is resulting in the growing demand for and sales of OTC drugs for the management of common coronavirus symptoms of cough, cold, flu, rhinitis, which is providing a growth opportunity to the global CCA treatment market during the forecasted period.

Scope of the report:

The report provides a comprehensive analysis of the global cough, cold & allergy (CCA) treatment market.
The major regional markets (The U.S., Europe5, Japan and ROW) have been analyzed.
The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
The competitive landscape of the market, along with the company profiles of leading players (Johnson & Johnson, Pfizer, Novartis AG, Merck & Co., Sanofi and Bristol-Myer Squibb) are also presented in detail.

Key Target Audience:

Cough, Cold & Allergy Drugs Manufacturers
Pharmaceuticals and Biopharmaceutical Firms
End Users (Hospitals and Research Institutes)
Investment Banks
Healthcare and Medical Consultants.
Government Bodies & Regulating Authorities


1. Overview
1.1 Introduction
1.2 Difference Between Cold and Allergy
Table 1: Difference Between Cold and Allergy
1.3 Classes of CCA Drugs
Table 2: Classes of CCA drugs
1.4 Types of CCA drugs
Table 3: Types of CCA drugs
2. Impact of COVID-19
2.1 Growth in Use of OTC Drugs
Table 4: Over-the-Counter Treatment Options for COVID-19
2.2 Corticosteroids For COVID-19
2.3 COVID-19 Impacts on People With Asthma and Allergies
3. Global Market Analysis
3.1 Global CCA Treatment Market by Value
Table 5: Global CCA Treatment Market by Value (2015-2019)
3.2 Global CCA Treatment Market Forecast by Value
Table 6: Global CCA Treatment Market Forecast by Value (2020-2024)
3.3 Global CCA Treatment Market Value by Product Category
Table 7: Global CCA Treatment Market Value by Product Category (2019)
3.3.1 Global Systemic Cold & Flu Treatment Market by Value
Table 8: Global Systemic Cold & Flu Treatment Market by Value (2015-2019)
3.3.2 Global Systemic Cold & Flu Treatment Market Forecast by Value
Table 9: Global Systemic Cold & Flu Treatment Market Forecast by Value (2020-2024)
3.3.3 Global Cough Remedies Market by Value
Table 10: Global Cough Remedies Market by Value (2015-2019)
3.3.4 Global Cough Remedies Market Forecast by Value
Table 11: Global Cough Remedies Market Forecast by Value (2020-2024)
3.3.5 Global Sore Throat Remedies & Medicated Confectionery Market by Value
Table 12: Global Sore Throat Remedies & Medicated Confectionery Market by Value (2015-2019)
3.3.6 Global Sore Throat Remedies & Medicated confectionery Market Forecast by Value
Table 13: Global Sore Throat Remedies & Medicated Confectionery Market Forecast by Value (2020-2024)
3.3.7 Global Allergy Remedies Market by Value
Table 14: Global Allergy Remedies Market by Value (2015-2019)
3.3.8 Global Allergy Remedies Market Forecast by Value
Table 15: Global Allergy Remedies Market Forecast by Value (2020-2024)
3.3.9 Global Tropical Decongestant Market by Value
Table 16: Global Tropical Decongestant Market by Value (2015-2019)
3.3.10 Global Tropical Decongestant Market Forecast by Value
Table 17: Global Tropical Decongestant Market Forecast by Value (2020-2024)
3.4 Global CCA Treatment Market Value by End-Users
Table 18: Global CCA Treatment Market Value by End-Users (2019)
3.4.1 Global Pharmacy CCA Treatment Market by Value
Table 19: Global Pharmacy CCA Treatment Market by Value (2015-2019)
3.4.2 Global Pharmacy CCA Treatment Market Forecast by Value
Table 20: Global Pharmacy CCA Treatment Market Forecast by Value (2020-2024)
3.4.3 Global Hospitals & Clinics CCA Treatment Market by Value
Table 21: Global Hospitals & Clinics CCA Treatment Market by Value (2015-2019)
3.4.4 Global Hospitals & Clinics CCA Treatment Market Forecast by Value
Table 22: Global Hospitals & Clinics CCA Treatment Market Forecast by Value (2020-2024)
3.5 Global CCA Treatment Market Value by Regions
Table 23: Global CCA Treatment Market Value by Regions (2019)
4. Regional Market Analysis
4.1 The U.S.
4.1.1 The U.S. CCA Treatment Market by Value
Table 24: The U.S. CCA Treatment Market by Value (2015-2019)
4.1.2 The U.S. CCA Treatment Market Forecast by Value
Table 25: The U.S. CCA Treatment Market Forecast by Value (2020-2024)
4.2 Europe5
4.2.1 Europe5 CCA Treatment Market by Value
Table 26: Europe5 CCA Treatment Market by Value (2015-2019)
4.2.2 Europe5 CCA Treatment Market Forecast by Value
Table 27: Europe5 CCA Treatment Market Forecast by Value (2020-2024)
4.3 Japan
4.3.1 Japan CCA Treatment Market by Value
Table 28: Japan CCA Treatment Market by Value (2015-2019)
4.3.2 Japan CCA Treatment Market Forecast by Value
Table 29: Japan CCA Treatment Market Forecast by Value (2020-2024)
4.4 ROW
4.4.1 ROW CCA Treatment Market by Value
Table 30: ROW CCA Treatment Market by Value (2015-2019)
4.4.2 ROW CCA Treatment Market Forecast by Value
Table 31: ROW CCA Treatment Market Forecast by Value (2020-2024)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Sales of Over-the-Counter (OTC) Medicines
Table 32: Global OTC Pharmaceutical Market (2015-2019)
5.1.2 Upswing in Air Pollution
Table 33: Air Quality Index (AQI) by highly Polluted Countries (2019)
5.1.3 Growth in Geriatric Population
Table 34: Global Geriatric Population – Age 65 and Above (2015-2019)
5.1.4 Increasing Pharmaceutical R&D Spending
Table 35: Global Pharmaceutical R&D Spending (2015-2019)
5.1.5 Rising Prevalence of Asthma
Table 36: Global Asthmatic Population – Per 100,000 People (2015-2019)
5.1.6 Upsurge in Healthcare Expenditures
Table 37: Global Healthcare Expenditure Per Capita (2015-2019)
5.2 Key Trends and Developments
5.2.1 Escalating Demand for Antihistamines Nasal Therapy
Table 38: Global Intranasal Antihistamines Market (2015-2019)
5.2.2 Accelerating Growth Rates of Infectious Diseases
Table 39: Global Growth Rate of Infectious Diseases Forecast (2017-2022)
5.2.3 Increasing Focus on Telehealth
Table 40: Global Telehealth Patient Population (2015-2019)
5.2.4 Growth in Pharmaceutical and Biotech Merger & Acquisition
Table 41: Global Pharmaceutical and Biotech M&A (2015-2019)
5.3 Challenges
5.3.1 Abusive Use of OTC CCA Drugs
5.3.2 Threats Associated with Drugs Counterfeiting
5.3.3 Legal Regulations
6.Competitive Landscape
6.1 Global Market
6.1.1 Key Players – Revenue Comparison
Table 42: Key Players – Revenue Comparison (2019)
6.1.2 Key Players – R&D Expenditure Comparison
Table 43: Key Players – R&D Expenditure Comparison (2019)
6.1.3 Key Players – Market Capitalization Comparison
Table 44: Key Players – Market Capitalization Comparison (2020)
7. Company Profiles
7.1 Johnson & Johnson
7.1.1 Business Overview
7.1.2 Financial Overview
Table 45: Johnson & Johnson Total Sales and Net Earnings (2015-2019)
Table 46: Johnson & Johnson Total Sales by Segments (2019)
Table 47: Johnson & Johnson Total Sales by Regions (2019)
7.1.3 Business Strategies
7.2 Pfizer
7.2.1 Business Overview
7.2.2 Financial Overview
Table 48: Pfizer Revenue and Net Income (2015-2019)
Table 49: Pfizer Revenue by Segments (2019)
Table 50: Pfizer Revenue by Regions (2019)
7.2.3 Business Strategies
7.3 Novartis AG
7.3.1 Business Overview
7.3.2 Financial Overview
Table 51: Novartis AG Net Sales and Net Income (2015-2019)
Table 52: Novartis AG Net Sales by Segments (2019)
Table 53: Novartis AG Net Sales by Regions (2019)
7.3.3 Business Strategies
7.4 Merck and Co.
7.4.1 Business Overview
7.4.2 Financial Overview
Table 54: Merck and Co. Sales and Net Income (2015-2019)
Table 55: Merck and Co. Sales by Segments (2019)
Table 56: Merck and Co. Sales by Regions (2019)
7.4.3 Business Strategies
7.5 Sanofi
7.5.1 Business Overview
7.5.2 Financial Overview
Table 57: Sanofi Net Sales and Net Income (2015-2019)
Table 58: Sanofi Net Sales by Segments (2019)
Table 59: Sanofi Net Sales by Regions (2019)
7.5.3 Business Strategies
7.6 Bristol-Myers Squibb
7.6.1 Business Overview
7.6.2 Financial Overview
Table 60: Bristol-Myers Squibb Total Revenue and Net Earnings (2015-2019)
Table 61: Bristol-Myers Squibb Total Revenue by Operations (2019)
Table 62: Bristol-Myers Squibb Total Revenue by Regions (2019)
7.6.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook